| 摘要 |
1292551 Quinoxaline di-N-oxide derivatives F HOFFMANN-LA ROCHE & CO AG 10 Dec 1970 [12 Dec 1969] 58719/70 Heading C2C Novel compounds of the general Formula I wherein R 1 is hydrogen, halogen, C 1-6 alkyl or C 1-6 alkoxy; R 2 is hydrogen, halogen, C 1-6 alkanoyloxy, aroyloxy, heterocyclylcarbonyloxy or heterocyclylcarbonylthio (wherein these groups are those which contain nitrogen, oxygen and/or sulphur in the ring and are derived from carboxylic acids wherein the carboxylic group is attached directly to the heterocyclic ring, the acids having up' to 10 carbon atoms in or directly attached to the ring), C 1-6 alkanoylthio or aroylthio wherein aroyl is derived from a carboxylic acid having up to 11 carbon atoms, R 3 is hydrogen or C 1-6 alkyl, n is 2 to 5 and X is C 1-6 alkoxy, C 1-6 alkylthio, di-C 1-6 alkylamino or a monocyclic 5- to 6-membered saturated heterocyclic amino group which may contain an additional nitrogen atom or an oxygen or sulphur atom may be prepared by (a) oxidation of a quinoxaline II or an N-monoxide thereof; (b) esterifying a quinoxaline N-dioxide carboxylic acid III or a reactive functional derivative thereof with an ester (c) when R 2 is hydrogen, reacting a benzofurazan oxide V with a compound VI wherein R 4 and R 5 each are hydrogen or C 1-6 alkyl or R 4 and R 5 together with the nitrogen to which they are attached represent pyrrolidino, piperidino or morpholino; and if desired (d) transesterifying the product obtained or where R 2 is hydrogen, replacing it with halogen and optionally replacing the halogen with C 1-6 alkanoyloxy, aroyloxy, heterocyclylcarbonyloxy, C 1-6 alkanoylthio, aroylthio or heterocyclylcarbonylthio. The novel compounds II may be prepared by reacting an o-phenylenediamine with an ether ester of (a) 2,3-dioxobutyric acid, (b) 2-hydroxy- 3 - oxo - butyric acid or (c) 2 - oxo - 3 - hydroxybutyric acid. The compounds of the Formula VI may be formed by reacting a ketone VII with ammonia or an appropriate primary or secondary amine. The compounds of the Formula VII may be prepared by reacting an appropriate ether alcohol derivative with diketene. Pharmaceutical compositions of the compounds I show bacteria pathogenic properties when administered orally or parenterally with the usual excipients. |
